Progenics Pharmaceuticals (PGNX)

Add to Watchlists
Create an Alert
11.26 +0.17  +1.53% NASDAQ Mar 24, 20:00 Delayed 2m USD

Progenics Pharmaceuticals Enterprise Value:

688.95M for March 23, 2017
View 4,000+ financial data types
Browse...
View Full Chart

Progenics Pharmaceuticals Enterprise Value Chart

Export Data
Save Image
Print Image

Progenics Pharmaceuticals Historical Enterprise Value Data

View and export this data going back to 1997. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
March 23, 2017 688.95M
March 22, 2017 700.18M
March 21, 2017 670.00M
March 20, 2017 702.99M
March 17, 2017 691.76M
March 16, 2017 713.52M
March 15, 2017 724.75M
March 14, 2017 698.08M
March 13, 2017 720.54M
March 10, 2017 716.33M
March 9, 2017 712.11M
March 8, 2017 683.34M
March 7, 2017 662.98M
March 6, 2017 681.93M
March 3, 2017 691.06M
March 2, 2017 696.67M
March 1, 2017 705.09M
Feb. 28, 2017 699.48M
Feb. 27, 2017 698.08M
Feb. 24, 2017 637.71M
Feb. 23, 2017 629.29M
Feb. 22, 2017 620.16M
Feb. 21, 2017 643.33M
Feb. 17, 2017 655.96M
Feb. 16, 2017 650.35M
   
Feb. 15, 2017 585.77M
Feb. 14, 2017 589.28M
Feb. 13, 2017 589.98M
Feb. 10, 2017 578.75M
Feb. 9, 2017 593.49M
Feb. 8, 2017 582.96M
Feb. 7, 2017 579.45M
Feb. 6, 2017 612.44M
Feb. 3, 2017 576.65M
Feb. 2, 2017 572.44M
Feb. 1, 2017 554.89M
Jan. 31, 2017 536.64M
Jan. 30, 2017 494.52M
Jan. 27, 2017 512.07M
Jan. 26, 2017 509.97M
Jan. 25, 2017 533.13M
Jan. 24, 2017 531.73M
Jan. 23, 2017 528.22M
Jan. 20, 2017 534.53M
Jan. 19, 2017 535.24M
Jan. 18, 2017 539.45M
Jan. 17, 2017 528.22M
Jan. 13, 2017 539.45M
Jan. 12, 2017 536.64M
Jan. 11, 2017 535.24M

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

About Enterprise Value

Click "Learn More" below to see how YCharts calculates Enterprise Value.

Enterprise Value (EV) is a valuation metric alternative to traditional market capitalization that reflects the market value of an entire business. Like market cap, EV is a measure of what the market believes a company is worth. Enterprise value captures the cost of an entire business, including debt and equity. It is a sum of claims of all preferred shareholders, debt holders, security holders, common equity holders, and minority shareholders - unlike market cap, which only captures the total value of common equity securities.

EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Learn More

Advertisement

PGNX Enterprise Value Benchmarks

Companies
Cytokinetics 394.84M
Sunesis Pharmaceuticals 66.75M
Synthetic Biologics 63.67M

PGNX Enterprise Value Range, Past 5 Years

Minimum 10.46M Nov 12 2012
Maximum 724.75M Mar 15 2017
Average 275.14M

PGNX Enterprise Value Excel Add-In Codes

  • Metric Code: enterprise_value
  • Latest data point: =YCP("PGNX", "enterprise_value")
  • Last 5 data points: =YCS("PGNX", "enterprise_value", -4)

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

You've hit the 10 page limit on YCharts.

Experience the power of YCharts.
Start your Free 7-Day Trial.

Start My Free Trial No credit card required.

Already a subscriber? Sign in.

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}
Start your free 7-Day Trial.

{{root.upsell.info.button_text}} No credit card required.

Already a subscriber? Sign in.